IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 40 filers reported holding IBERE PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $729 | -75.7% | 40,932 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 40,932 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -62.5% | 40,932 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -63.6% | 40,932 | 0.0% | 0.00% | – |
| Q4 2021 | $22,000 | -8.3% | 40,932 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | +140.0% | 40,932 | +227.5% | 0.00% | – |
| Q2 2021 | $10,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 9,800 | $108,054 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |